Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Quercetin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Mar 2015 Planned End Date changed from 1 Apr 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 17 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2014 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.